6-129267114-G-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_000426.4(LAMA2):​c.2217G>T​(p.Trp739Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00037 in 1,608,450 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00054 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00035 ( 3 hom. )

Consequence

LAMA2
NM_000426.4 missense

Scores

1
7
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:3

Conservation

PhyloP100: 2.34

Publications

9 publications found
Variant links:
Genes affected
LAMA2 (HGNC:6482): (laminin subunit alpha 2) Laminin, an extracellular protein, is a major component of the basement membrane. It is thought to mediate the attachment, migration, and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. It is composed of three subunits, alpha, beta, and gamma, which are bound to each other by disulfide bonds into a cross-shaped molecule. This gene encodes the alpha 2 chain, which constitutes one of the subunits of laminin 2 (merosin) and laminin 4 (s-merosin). Mutations in this gene have been identified as the cause of congenital merosin-deficient muscular dystrophy. Two transcript variants encoding different proteins have been found for this gene. [provided by RefSeq, Jul 2008]
LAMA2 Gene-Disease associations (from GenCC):
  • congenital merosin-deficient muscular dystrophy 1A
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P
  • LAMA2-related muscular dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • muscular dystrophy, limb-girdle, autosomal recessive 23
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011787742).
BP6
Variant 6-129267114-G-T is Benign according to our data. Variant chr6-129267114-G-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 435712.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000539 (82/152092) while in subpopulation EAS AF = 0.0122 (63/5154). AF 95% confidence interval is 0.00981. There are 0 homozygotes in GnomAd4. There are 48 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000426.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LAMA2
NM_000426.4
MANE Select
c.2217G>Tp.Trp739Cys
missense
Exon 16 of 65NP_000417.3
LAMA2
NM_001079823.2
c.2217G>Tp.Trp739Cys
missense
Exon 16 of 64NP_001073291.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LAMA2
ENST00000421865.3
TSL:5 MANE Select
c.2217G>Tp.Trp739Cys
missense
Exon 16 of 65ENSP00000400365.2
LAMA2
ENST00000618192.5
TSL:5
c.2217G>Tp.Trp739Cys
missense
Exon 16 of 66ENSP00000480802.2
LAMA2
ENST00000617695.5
TSL:5
c.2217G>Tp.Trp739Cys
missense
Exon 16 of 64ENSP00000481744.2

Frequencies

GnomAD3 genomes
AF:
0.000540
AC:
82
AN:
151974
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00260
Gnomad EAS
AF:
0.0124
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00105
AC:
264
AN:
251002
AF XY:
0.000966
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00208
Gnomad EAS exome
AF:
0.0121
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000353
Gnomad OTH exome
AF:
0.000816
GnomAD4 exome
AF:
0.000352
AC:
513
AN:
1456358
Hom.:
3
Cov.:
30
AF XY:
0.000375
AC XY:
272
AN XY:
724864
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33334
American (AMR)
AF:
0.00
AC:
0
AN:
44668
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
45
AN:
26070
East Asian (EAS)
AF:
0.00960
AC:
381
AN:
39670
South Asian (SAS)
AF:
0.000348
AC:
30
AN:
86160
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53412
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5754
European-Non Finnish (NFE)
AF:
0.00000723
AC:
8
AN:
1107122
Other (OTH)
AF:
0.000814
AC:
49
AN:
60168
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
32
64
97
129
161
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000539
AC:
82
AN:
152092
Hom.:
0
Cov.:
32
AF XY:
0.000646
AC XY:
48
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41510
American (AMR)
AF:
0.00
AC:
0
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.00260
AC:
9
AN:
3468
East Asian (EAS)
AF:
0.0122
AC:
63
AN:
5154
South Asian (SAS)
AF:
0.00166
AC:
8
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10592
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
67972
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000483
Hom.:
3
Bravo
AF:
0.000616
ExAC
AF:
0.000939
AC:
114
Asia WGS
AF:
0.00520
AC:
18
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Merosin deficient congenital muscular dystrophy Uncertain:1
Jan 17, 2017
Counsyl
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.

not provided Uncertain:1
Apr 03, 2019
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Congenital muscular dystrophy due to partial LAMA2 deficiency Uncertain:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.

not specified Benign:1
Oct 19, 2015
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

LAMA2-related muscular dystrophy Benign:1
Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Muscular dystrophy, limb-girdle, autosomal recessive 23 Benign:1
Jun 22, 2018
Knight Diagnostic Laboratories, Oregon Health and Sciences University
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.85
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.17
CADD
Pathogenic
31
DANN
Uncertain
0.99
DEOGEN2
Benign
0.011
T
Eigen
Uncertain
0.55
Eigen_PC
Uncertain
0.58
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Uncertain
0.93
D
MetaRNN
Benign
0.012
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.6
L
PhyloP100
2.3
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-1.1
N
REVEL
Benign
0.12
Sift
Uncertain
0.020
D
Polyphen
1.0
D
Vest4
0.77
MutPred
0.65
Loss of catalytic residue at W739 (P = 0.0034)
MVP
0.62
MPC
0.56
ClinPred
0.043
T
GERP RS
5.7
Varity_R
0.18
gMVP
0.76
Mutation Taster
=75/25
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.14
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs192317605; hg19: chr6-129588259; COSMIC: COSV70346672; API